SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: WTDEC who wrote (23152)7/13/1998 11:34:00 PM
From: RevMikeB  Read Replies (2) | Respond to of 32384
 
I was wondering if most of the people on the this thread believe that if Ontack is approved by FDA, Ligand's stock will go up on the news? With the 36 million payment that would be due, it makes me wonder. SRGN will go up, but what about LGND, and how much would you guess it will move?



To: WTDEC who wrote (23152)7/14/1998 10:48:00 AM
From: Flagrante Delictu  Respond to of 32384
 
WTDEC, OFF TOPIC Since "pipette" is the diminutive of pipe and could, therefore, be classified as " a little pipe", and since it's rare to come upon a little pipe in unusual places or circumstances, I cannot deny my interest in collecting pipette. Celeryroot is wise, indeed.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News